Skip to content

Author: Visceral

Major gaps exist in patient understanding of genomic test results, Lung-MAP study shows

A majority of cancer patients don’t understand key aspects of the genomic test results they receive as participants in biomarker-driven clinical trials, according to a first-of-its-kind pilot study conducted under the Lung Cancer Master Protocol (Lung-MAP). In a September 9 presentation at the World Conference on Lung Cancer in Barcelona, Lung-MAP investigator Joshua A. Roth, PhD,…

Lung-MAP Precision Medicine Trial Expands To Include More Patients

For Immediate Release Jan. 29, 2019 Please Contact: Ryan Hohman, Vice President – Public Affairs, Friends of Cancer Research; 202-944-6708 Wendy Lawton, Communications Manager, SWOG; 503.348.8675 Lung-MAP Precision Medicine Trial Expands To Include More Patients Washington, DC – The Lung Cancer Master Protocol (Lung-MAP), the first precision medicine trial in lung cancer supported by the…

Thoracic Oncologist Honored with Lectureship Award

Foundation for the National Institutes of Health and Cancer Research Institute Announce New Collaboration in Cancer Immunotherapy

More Umbrella Trials Needed to Advance Precision Medicine in Lung Cancer, Expert Suggests

Further Optimizing the Treatment of Non-Driver NSCLC

Future Focus on Combinations, Biomarkers in Metastatic NSCLC

Master Protocols Are Both Welcome And Inevitable – US FDA's Woodcock

Master Protocols in Practice

Bayesian Adaptive Randomization: A Q&A With Brian M. Alexander MD, PhD